Evidence map›Paper›PMID 33659960›Full record

ReviewFaculty reviews2020

An overview of the treatment of cutaneous leishmaniasis.

Talissa F Garza-Tovar, Marco I Sacriste-Hernández, Eder R Juárez-Durán, Roberto Arenas

Abstract readReview
In one paragraph

Review in Faculty reviews, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Article
  7. Article
  8. Silver-Pharmaceuticals (Basel, Switzerland) · 2026
    Article
  9. Econazole Exhibits In Vitro and In Vivo Efficacy AgainstPharmaceuticals (Basel, Switzerland) · 2026
    Article
  10. Autochthonous canine cutaneous leishmaniasis caused byCurrent research in parasitology & vector-borne diseases · 2026
    Article
  11. Review
  12. Review
  13. Article
  14. Leishmaniasis.Nature reviews. Disease primers · 2025
    Review
  15. Antimicrobial agents and chemotherapy · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Talissa F Garza-TovarDermatology Department, Hospital of Specialties 25 IMSS, Monterrey, Nuevo León.
Marco I Sacriste-HernándezDermatology Department, Hospital of Specialties 25 IMSS, Monterrey, Nuevo León.
Eder R Juárez-DuránMycology Section, "Dr. Manuel Gea Gonzalez" General Hospital, Mexico City, Mexico.
Roberto ArenasMycology Section, "Dr. Manuel Gea Gonzalez" General Hospital, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-2992-9564

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leishmaniasis is a neglected tropical disease caused by species of

Indexed as

AntimonialsLeishmaniasisTreatment

Identifiers

PMID33659960
PMCPMC7886081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.